1. FarooqiIS, JebbSA, LangmackG, LawrenceE, CheethamCH, et al. (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341: 879–884.
2. MontagueCT, FarooqiIS, WhiteheadJP, SoosMA, RauH, et al. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903–908.
3. PearsonER, FlechtnerI, NjolstadPR, MaleckiMT, FlanaganSE, et al. (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355: 467–477.
4. YamagataK, OdaN, KaisakiPJ, MenzelS, FurutaH, et al. (1996) Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384: 455–458.
5. BrunkowME, GardnerJC, Van NessJ, PaeperBW, KovacevichBR, et al. (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68: 577–589.
6. ChandrasekharappaSC, GuruSC, ManickamP, OlufemiSE, CollinsFS, et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404–407.
7. GongY, SleeRB, FukaiN, RawadiG, Roman-RomanS, et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513–523.
8. CollinsFS, RossantJ, WurstW (2007) A mouse for all reasons. Cell 128: 9–13.
9. SkarnesWC, RosenB, WestAP, KoutsourakisM, BushellW, et al. (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474: 337–342.
10. JohnellO, KanisJA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17: 1726–1733.
11. RalstonSH, UitterlindenAG (2010) Genetics of osteoporosis. Endocr Rev 31: 629–662.
12. RivadeneiraF, StyrkarsdottirU, EstradaK, HalldorssonBV, HsuYH, et al. (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41: 1199–1206.
13. CirulliET, GoldsteinDB (2010) Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 11: 415–425.
14. BlackDM, ThompsonDE, BauerDC, EnsrudK, MuslinerT, et al. (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85: 4118–4124.
15. MackeyDC, BlackDM, BauerDC, McCloskeyEV, EastellR, et al. (2011) Effects of antiresorptive treatment on non-vertebral fracture outcomes. J Bone Miner Res 26: 2411–2418.
16. BoydenLM, MaoJ, BelskyJ, MitznerL, FarhiA, et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513–1521.
17. RachnerTD, KhoslaS, HofbauerLC (2011) Osteoporosis: now and the future. Lancet 377: 1276–1287.
18. BrownSD, ChambonP, de AngelisMH (2005) EMPReSS: standardized phenotype screens for functional annotation of the mouse genome. Nat Genet 37: 1155.
19. JusticeMJ (2008) Removing the cloak of invisibility: phenotyping the mouse. Dis Model Mech 1: 109–112.
20. KarpNA, BakerLA, GerdinAK, AdamsNC, Ramirez-SolisR, et al. (2010) Optimising experimental design for high-throughput phenotyping in mice: a case study. Mamm Genome 21: 467–476.
21. Hardisty-HughesRE, ParkerA, BrownSD (2010) A hearing and vestibular phenotyping pipeline to identify mouse mutants with hearing impairment. Nat Protoc 5: 177–190.
22. BoskeyAL, MooreDJ, AmlingM, CanalisE, DelanyAM (2003) Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res 18: 1005–1011.
23. DelanyAM, AmlingM, PriemelM, HoweC, BaronR, et al. (2000) Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest 105: 915–923.
24. Everitt B, editor. An R and S-PLUS Companion to Multivariate Analysis. London: Springer.
25. MitchellAFS, KrzanowskiWJ (1985) The Mahalanobis distance and elliptic distributions. Biometrika 72: 464–467.
26. RousseeuwPJ (1985) Multivariate estimation with high breakdown point;. W. Grossmann GP, I. Vinceze, and W. Wertz, Eds., editor The Netherlands: Reidel. 283–297.
27. RousseeuwPJ, Van ZomerenBC (1990) Unmasking Multivariate Outliers and Leverage Points. Journal of the American Statistical Association 85: 633–639.
28. AmmannP, RizzoliR (2003) Bone strength and its determinants. Osteoporos Int 14 Suppl 3: S13–18.
29. BoyleWJ, SimonetWS, LaceyDL (2003) Osteoclast differentiation and activation. Nature 423: 337–342.
30. HaradaS, RodanGA (2003) Control of osteoblast function and regulation of bone mass. Nature 423: 349–355.
31. DickensonRP, HuttonWC, StottJR (1981) The mechanical properties of bone in osteoporosis. J Bone Joint Surg Br 63-B: 233–238.
32. Marchler-BauerA, AndersonJB, ChitsazF, DerbyshireMK, DeWeese-ScottC, et al. (2009) CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res 37: D205–210.
33. DaileyL, BasilicoC (2001) Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J Cell Physiol 186: 315–328.
34. LaudetV, StehelinD, CleversH (1993) Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res 21: 2493–2501.
35. LoveJJ, LiX, CaseDA, GieseK, GrosschedlR, et al. (1995) Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376: 791–795.
36. PohlerJR, NormanDG, BramhamJ, BianchiME, LilleyDM (1998) HMG box proteins bind to four-way DNA junctions in their open conformation. EMBO J 17: 817–826.
37. BernardP, TangP, LiuS, DewingP, HarleyVR, et al. (2003) Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum Mol Genet 12: 1755–1765.
38. MundlosS, OlsenBR (1997) Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11: 125–132.
39. MacDonaldBT, TamaiK, HeX (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9–26.
40. BalemansW, Van HulW (2007) The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology 148: 2622–2629.
41. BaronR, RawadiG (2007) Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep 5: 73–80.
42. ChanA, van BezooijenRL, LowikCW (2007) A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists. Curr Opin Investig Drugs 8: 293–298.
43. LuytenFP, TylzanowskiP, LoriesRJ (2009) Wnt signaling and osteoarthritis. Bone 44: 522–527.
44. GiangrecoA, JensenKB, TakaiY, MiyoshiJ, WattFM (2009) Necl2 regulates epidermal adhesion and wound repair. Development 136: 3505–3514.
45. KuramochiM, FukuharaH, NobukuniT, KanbeT, MaruyamaT, et al. (2001) TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 27: 427–430.
46. BiedererT, SaraY, MozhayevaM, AtasoyD, LiuX, et al. (2002) SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 297: 1525–1531.
47. TakayanagiY, FujitaE, YuZ, YamagataT, MomoiMY, et al. (2010) Impairment of social and emotional behaviors in Cadm1-knockout mice. Biochem Biophys Res Commun 396: 703–708.
48. GiangrecoA, HosteE, TakaiY, RosewellI, WattFM (2012) Epidermal Cadm1 expression promotes autoimmune alopecia via enhanced T cell adhesion and cytotoxicity. J Immunol 188: 1514–1522.
49. ItoA, HagiyamaM, OonumaJ (2008) Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1. J Smooth Muscle Res 44: 83–93.
50. FujitaE, KourokuY, OzekiS, TanabeY, ToyamaY, et al. (2006) Oligo-astheno-teratozoospermia in mice lacking RA175/TSLC1/SynCAM/IGSF4A, a cell adhesion molecule in the immunoglobulin superfamily. Mol Cell Biol 26: 718–726.
51. RauchF, GlorieuxFH (2004) Osteogenesis imperfecta. Lancet 363: 1377–1385.
52. TatibanaM, KitaK, TairaM, IshijimaS, SonodaT, et al. (1995) Mammalian phosphoribosyl-pyrophosphate synthetase. Adv Enzyme Regul 35: 229–249.
53. KatashimaR, IwahanaH, FujimuraM, YamaokaT, ItakuraM (1998) Assignment of the human phosphoribosylpyrophosphate synthetase-associated protein 41 gene (PRPSAP2) to 17p11.2–p12. Genomics 54: 180–181.
54. BothJ, WuT, BrasJ, SchaapGR, BaasF, et al. (2012) Identification of novel candidate oncogenes in chromosome region 17p11.2–p12 in human osteosarcoma. PLoS One 7: e30907.
55. SundbergBE, WaagE, JacobssonJA, StephanssonO, RumaksJ, et al. (2008) The evolutionary history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32, SLC36, and SLC38. J Mol Neurosci 35: 179–193.
56. Franchi-GazzolaR, Dall'AstaV, SalaR, VisigalliR, BevilacquaE, et al. (2006) The role of the neutral amino acid transporter SNAT2 in cell volume regulation. Acta Physiol (Oxf) 187: 273–283.
57. KronenbergHM (2003) Developmental regulation of the growth plate. Nature 423: 332–336.
58. HiraokaS, FuruichiT, NishimuraG, ShibataS, YanagishitaM, et al. (2007) Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human. Nat Med 13: 1363–1367.
59. Superti-FurgaA, HastbackaJ, RossiA, van der HartenJJ, WilcoxWR, et al. (1996) A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. Ann N Y Acad Sci 785: 195–201.
60. LiX, OminskyMS, NiuQT, SunN, DaughertyB, et al. (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23: 860–869.
61. AkhterMP, WellsDJ, ShortSJ, CullenDM, JohnsonML, et al. (2004) Bone biomechanical properties in LRP5 mutant mice. Bone 35: 162–169.
62. LeeSW, ChoYS, NaJM, ParkUH, KangM, et al. (2010) ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1. J Biol Chem 285: 18–29.
63. FisherCL, LeeI, BloyerS, BozzaS, ChevalierJ, et al. (2010) Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice. Dev Biol 337: 9–15.
64. WellikDM (2007) Hox patterning of the vertebrate axial skeleton. Dev Dyn 236: 2454–2463.
65. WilliamsJA, KondoN, OkabeT, TakeshitaN, PilchakDM, et al. (2009) Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse. Dev Biol 328: 315–327.
66. HoischenA, van BonBW, Rodriguez-SantiagoB, GilissenC, VissersLE, et al. (2011) De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 43: 729–731.
67. SchultzDC, AyyanathanK, NegorevD, MaulGG, RauscherFJ3rd (2002) SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16: 919–932.
68. YangL, XiaL, WuDY, WangH, ChanskyHA, et al. (2002) Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 21: 148–152.
69. NifujiA, IdenoH, OhyamaY, TakanabeR, ArakiR, et al. (2010) Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation. Exp Cell Res 316: 1127–1136.
70. TakadaI, MiharaM, SuzawaM, OhtakeF, KobayashiS, et al. (2007) A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 9: 1273–1285.
71. HisanoY, KobayashiN, KawaharaA, YamaguchiA, NishiT (2011) The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. J Biol Chem 286: 1758–1766.
72. IshiiM, EgenJG, KlauschenF, Meier-SchellersheimM, SaekiY, et al. (2009) Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458: 524–528.
73. IshiiT, ShimazuY, NishiyamaI, KikutaJ, IshiiM (2011) The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. Mol Cells 31: 399–403.
74. PedersonL, RuanM, WestendorfJJ, KhoslaS, OurslerMJ (2008) Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 105: 20764–20769.
75. RyuJ, KimHJ, ChangEJ, HuangH, BannoY, et al. (2006) Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25: 5840–5851.
76. ChuY, YangX (2011) SUMO E3 ligase activity of TRIM proteins. Oncogene 30: 1108–1116.
77. NapolitanoLM, JaffrayEG, HayRT, MeroniG (2011) Functional interactions between ubiquitin E2 enzymes and TRIM proteins. Biochem J 434: 309–319.
78. OzatoK, ShinDM, ChangTH, MorseHC3rd (2008) TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8: 849–860.
79. WangY, LiY, QiX, YuanW, AiJ, et al. (2004) TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. Biochem Biophys Res Commun 323: 9–16.
80. KomoriT (2006) Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99: 1233–1239.
81. WagnerEF (2010) Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis 69 Suppl 1: i86–88.
82. RichardsJB, RivadeneiraF, InouyeM, PastinenTM, SoranzoN, et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371: 1505–1512.
83. StyrkarsdottirU, HalldorssonBV, GretarsdottirS, GudbjartssonDF, WaltersGB, et al. (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358: 2355–2365.
84. EstradaK, StyrkarsdottirU, EvangelouE, HsuYH, DuncanEL, et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44: 491–501.
85. BassettJH, BoydeA, HowellPG, BassettRH, GallifordTM, et al. (2010) Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci U S A 107: 7604–7609.
86. ParfittAM, DreznerMK, GlorieuxFH, KanisJA, MallucheH, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595–610.
87. Venables WN, Ripley BD (2002) Modern Applied Statistics with S New York, NY, USA: Springer.